GO:0010165 response to X-ray: Cellular Stress Response, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0010165 response to X-ray describes any process that changes a cell or organism's state or activity after exposure to X-ray radiation.
• X-rays induce DNA damage, oxidative stress, and transcriptional reprogramming that can be measured by transcriptomics and functional assays.
• Key genes in the response include TP53, ATM, CHEK2, CDKN1A, and STING1, which coordinate DNA repair, cell cycle arrest, and immune signaling.
• X-ray responses are exploited in cancer therapy, where radiation activates immunogenic cell death and STING-dependent antitumor immunity.
• Model systems for studying response to X-ray include zebrafish embryos, mouse lung fibrosis models, and osteosarcoma cell lines.
• CRISPR knockout, knock-in, and overexpression models enable causal testing of candidate genes in the X-ray response pathway.
Description
Response to X-ray (GO:0010165) is a biological process that encompasses the molecular, cellular, and physiological changes triggered by X-ray radiation. X-rays are a form of ionizing electromagnetic radiation with wavelengths between 10 nanometers and 100 picometers, and they are widely used in medical imaging and radiotherapy. The cellular response to X-rays includes DNA damage recognition, activation of checkpoint pathways, oxidative stress, and transcriptional reprogramming that can determine cell survival or death. Understanding this process is critical for optimizing radiotherapy, predicting normal tissue toxicity, and identifying radiosensitizing targets. Research on GO:0010165 has revealed that X-ray exposure activates complex signaling networks involving DNA damage sensors, transcription factors, and immune modulators. For example, X-ray irradiation can induce STING pathway activation in melanoma, linking radiation to antitumor immunity. In osteosarcoma cells, X-ray responses are modulated by lysophosphatidic acid receptors, highlighting cell-type-specific mechanisms. These findings underscore the importance of context-dependent regulation in the X-ray response. This article provides a research-grade overview of GO:0010165, integrating authoritative QuickGO annotation with verified PubMed literature. It covers the definition, key genes, regulatory mechanisms, disease relevance, and experimental models, with a focus on how CRISPR-based tools can accelerate discovery in this field.
response to X-ray At A Glance
| GO ID | GO:0010165 |
|---|---|
| GO term | response to X-ray |
| Ontology | biological_process |
| Synonym | response to X-ray radiation stimulus |
| Definition | Any process that results in a change in state or activity of a cell or an organism as a result of X-ray radiation. |
| Major function | Cellular and organismal adaptation to X-ray-induced damage and stress |
| Related processes | DNA damage response, oxidative stress response, apoptosis, immune activation |
| Key regulators | TP53, ATM, CHEK2, CDKN1A, STING1, LPA receptors |
| Research applications | Radiotherapy optimization, radiosensitivity testing, biomarker discovery |
What Is GO:0010165?
According to the Gene Ontology, response to X-ray (GO:0010165) is defined as any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of X-ray radiation. An X-ray is a form of electromagnetic radiation with a wavelength in the range of 10 nanometers to 100 picometers, corresponding to frequencies in the range of 30 PHz to 3 EHz. This term captures the full spectrum of biological responses, from immediate molecular events such as DNA damage and oxidative stress to long-term outcomes like cell death, survival, or immune activation.
Why Is response to X-ray Important in Cell Biology?
Response to X-ray is fundamentally important because X-rays are a mainstay of cancer radiotherapy and medical imaging, and the biological response determines therapeutic efficacy and normal tissue toxicity. Elucidating the molecular players in GO:0010165 can reveal predictive biomarkers and targets for radiosensitization or radioprotection. Moreover, X-ray-induced immune activation through pathways like STING has opened new avenues for combining radiotherapy with immunotherapy. Thus, understanding this process has direct translational impact in oncology and beyond.
• X-rays are widely used in radiotherapy, and the response to X-ray determines tumor control and normal tissue damage.
• The response involves DNA repair, cell cycle checkpoints, and apoptosis, which are critical for genomic stability.
• X-ray exposure can activate immune signaling, such as the STING pathway, linking radiation to antitumor immunity.
• Differential responses to X-rays versus protons can identify combinatorial therapy targets in lymphoma.
• X-ray-induced oxidative stress and inflammation can cause developmental defects, as shown in zebrafish embryos.
• Lung function monitoring after X-ray exposure can assess treatment response in fibrosis models.
• Radiomics using X-ray and MRI can predict neoadjuvant chemotherapy response in osteosarcoma.
• Understanding X-ray response mechanisms can inform radioprotective strategies for healthy tissues.
What Happens During response to X-ray?
Immediate Physical and Chemical Damage
In simple terms: X-rays hit cells and directly damage DNA and other molecules, or create reactive oxygen species that cause further damage.
When cells are exposed to X-rays, the radiation can directly ionize DNA and other macromolecules, leading to single- and double-strand breaks. Indirectly, X-rays generate reactive oxygen species (ROS) through water radiolysis, which oxidize lipids, proteins, and nucleic acids. This initial damage triggers a cascade of cellular responses. For example, in zebrafish embryos, panoramic dental X-ray exposure leads to oxidative stress, inflammation, and apoptosis-mediated developmental defects. The physical and chemical damage is the first step in the response to X-ray.
DNA Damage Sensing and Signaling
In simple terms: Special sensor proteins detect DNA breaks and activate a signaling network that tells the cell to repair damage or stop dividing.
Following X-ray-induced DNA damage, sensor kinases such as ATM and ATR are recruited to damage sites and initiate a phosphorylation cascade. This activates checkpoint kinases like CHEK2, which in turn regulate downstream effectors including TP53. The DNA damage response coordinates cell cycle arrest, DNA repair, and apoptosis. Transcriptome studies after X-ray exposure in lymphoma cells revealed differential expression of genes involved in DNA repair and cell cycle control, identifying novel candidate targets. This signaling is a hallmark of the cellular response to X-ray.
Transcriptional Reprogramming
In simple terms: The cell changes which genes are turned on or off to adapt to the stress caused by X-rays.
X-ray exposure leads to widespread changes in gene expression. For instance, differential transcriptome analysis of lymphoma cells after proton versus X-ray radiation revealed distinct gene expression signatures, including genes related to DNA repair, apoptosis, and immune response. In melanoma, X-ray-responsive dissolving microneedles activated the STING pathway, leading to increased expression of interferon-stimulated genes. Similarly, X-ray stimulation induced NQO1-dependent cascade reactions that enhanced immunogenicity in cancer cells. These transcriptional changes are central to the biological response to X-ray.
Cell Fate Decisions: Survival, Senescence, or Death
In simple terms: Depending on the extent of damage and cellular context, cells may repair themselves, permanently stop dividing, or undergo programmed cell death.
The ultimate outcome of the X-ray response is a cell fate decision. TP53 plays a pivotal role by inducing CDKN1A (p21) to cause cell cycle arrest, allowing time for DNA repair. If damage is irreparable, TP53 can trigger apoptosis. In osteosarcoma cells, activation of lysophosphatidic acid receptors LPA3 and LPA2 modulated cellular responses to X-ray irradiation, influencing survival and death pathways. In zebrafish embryos, X-ray exposure induced apoptosis-mediated developmental defects. Thus, the balance between pro-survival and pro-death signals determines the physiological outcome.
Immune and Microenvironmental Interactions
In simple terms: X-ray damage can alert the immune system and change the behavior of surrounding tissues.
X-ray irradiation can induce immunogenic cell death and activate innate immune pathways. For example, X-ray-responsive microneedles activated the STING pathway in cutaneous melanoma, potentiating radio-immunotherapy. X-ray stimulation also triggered NQO1-dependent cascade reactions that induced strong immunogenicity for MRI-guided cancer therapy. These findings highlight that the response to X-ray extends beyond the irradiated cell to affect the tumor microenvironment and systemic immunity.
Key Genes Involved in GO:0010165 response to X-ray
The following genes and proteins are central to the cellular response to X-ray, as supported by transcriptomic and functional studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TP53 | Master transcription factor regulating cell cycle arrest, apoptosis, and DNA repair | Frequently mutated in cancers; determines radiosensitivity |
| ATM | DNA damage sensor kinase that initiates checkpoint signaling | Key regulator of X-ray-induced DNA damage response |
| CHEK2 | Checkpoint kinase that amplifies ATM signaling | Modulates cell cycle arrest and repair after X-ray |
| CDKN1A | Cyclin-dependent kinase inhibitor mediating p53-dependent cell cycle arrest | Biomarker of X-ray response |
| STING1 | Adaptor protein in cytosolic DNA sensing and interferon activation | Mediates X-ray-induced antitumor immunity |
| NQO1 | Quinone oxidoreductase involved in redox cycling and bioactivation | X-ray stimulates NQO1-dependent cascade reactions |
| LPA3 | Lysophosphatidic acid receptor 3 | Modulates osteosarcoma cell response to X-ray |
| LPA2 | Lysophosphatidic acid receptor 2 | Modulates osteosarcoma cell response to X-ray |
| H2AX | Histone variant phosphorylated at DNA double-strand breaks | Marker of X-ray-induced DNA damage |
| MDM2 | E3 ubiquitin ligase regulating p53 stability | Modulates p53 activity after X-ray |
| BAX | Pro-apoptotic Bcl-2 family member | Mediates X-ray-induced apoptosis |
| CASP3 | Executioner caspase in apoptosis | Effector of X-ray-induced cell death |
| IL6 | Pro-inflammatory cytokine | Induced by X-ray and associated with inflammation |
| TNF | Pro-inflammatory cytokine | Induced by X-ray and associated with inflammation |
| GADD45A | Growth arrest and DNA damage-inducible gene | Upregulated after X-ray |
| RAD51 | RecA homolog involved in homologous recombination repair | Critical for repair of X-ray-induced DNA damage |
| XRCC1 | Scaffold protein in base excision repair | Participates in repair of X-ray-induced single-strand breaks |
| PARP1 | Poly(ADP-ribose) polymerase involved in DNA repair | Senses and repairs X-ray-induced DNA damage |
How Is response to X-ray Regulated?
The response to X-ray is tightly regulated at multiple levels. At the transcriptional level, TP53 induces a battery of target genes including CDKN1A, MDM2, and GADD45A to coordinate cell cycle arrest and repair. Post-translational modifications, such as phosphorylation by ATM and CHEK2, control the activity of key effectors. In osteosarcoma cells, lysophosphatidic acid receptor signaling through LPA3 and LPA2 modulates the response to X-ray, suggesting G-protein-coupled receptor pathways as regulators. Additionally, X-ray-induced oxidative stress can activate NRF2-mediated antioxidant responses, and STING-dependent interferon signaling can amplify immune responses. These regulatory layers ensure a context-dependent and dynamic response to X-ray.
response to X-ray and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TP53 | Cancer radiosensitivity and Li-Fraumeni syndrome | TP53 knockout or point-mutant cell lines |
| STING1 | Antitumor immunity and radio-immunotherapy | STING1 knockout melanoma models |
| NQO1 | Cancer radio-chemodynamic therapy | NQO1-overexpressing or knockout cancer cells |
| LPA3/LPA2 | Osteosarcoma progression and X-ray response | LPA receptor knockout osteosarcoma cells |
| BAX/CASP3 | Apoptosis-mediated developmental defects | Zebrafish embryos with CRISPR knockout |
Cancer and Radiotherapy
The response to X-ray is central to cancer radiotherapy. Tumors with defective DNA damage response, such as TP53 mutations, may exhibit altered radiosensitivity. X-ray-induced STING activation can enhance antitumor immunity, providing a rationale for combining radiotherapy with immune checkpoint inhibitors. In osteosarcoma, LPA receptor signaling modulates X-ray response and may influence treatment outcomes. Radiomics using X-ray and MRI can predict neoadjuvant chemotherapy response in osteosarcoma, linking imaging features to underlying biology.
Developmental Defects and Inflammation
X-ray exposure during development can cause oxidative stress, inflammation, and apoptosis, leading to developmental defects. In zebrafish embryos, panoramic dental X-ray exposure resulted in increased ROS, inflammatory cytokine expression, and apoptosis-mediated malformations. This highlights the teratogenic potential of X-rays and the importance of understanding the response to X-ray in sensitive populations.
Lung Fibrosis and Tissue Remodeling
X-ray-based lung function measurement has been used to monitor treatment response in a mouse model of lung fibrosis, where Nintedanib treatment was assessed longitudinally. This demonstrates how X-ray imaging can be applied to evaluate disease progression and therapeutic efficacy in fibrotic diseases, which involve aberrant responses to radiation and tissue injury.
From response to X-ray-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does TP53 loss alter X-ray-induced cell cycle arrest? | TP53 knockout cell line (e.g., HCT116 TP53-/-) |
| Does STING1 mediate X-ray-induced interferon signaling? | STING1 knockout melanoma cells or mouse models |
| Can a point mutation in ATM affect radiosensitivity? | ATM point-mutant knock-in cell lines |
| Does NQO1 overexpression enhance X-ray-induced immunogenicity? | NQO1 overexpression in cancer cells |
| What is the role of LPA3 in osteosarcoma X-ray response? | LPA3 knockout or overexpression osteosarcoma cells |
| Can a tagged knock-in of H2AX track DNA damage in real time? | H2AX-GFP knock-in cell lines |
How to Study the response to X-ray Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Transcriptome response to X-ray |
| gamma-H2AX foci staining | DNA double-strand breaks | Quantification of X-ray-induced DNA damage |
| Comet assay | DNA strand breaks and repair | Assessment of genotoxicity after X-ray |
| ROS detection (DCFH-DA) | Reactive oxygen species levels | Oxidative stress after X-ray |
| Annexin V/PI staining | Apoptosis and necrosis | Cell death after X-ray |
| Caspase activity assay | Caspase-3/7 activity | Apoptosis execution after X-ray |
| X-ray radiomics | Imaging features correlated with biology | Prediction of chemotherapy response |
| Lung function measurement | Respiratory mechanics | Monitoring fibrosis treatment response |
Transcriptomics and RNA-seq
RNA sequencing after X-ray exposure can reveal global changes in gene expression. Differential transcriptome analysis of lymphoma cells after proton versus X-ray radiation identified novel candidate targets for combinatorial therapy. This method is powerful for discovering pathways and biomarkers associated with the response to X-ray.
DNA Damage and Repair Assays
Comet assay, gamma-H2AX foci staining, and pulsed-field gel electrophoresis measure DNA damage and repair kinetics after X-ray. These assays are essential for quantifying the immediate effects of X-ray and assessing the function of repair genes.
Oxidative Stress and Apoptosis Detection
ROS levels can be measured using fluorescent probes such as DCFH-DA, while apoptosis can be assessed by Annexin V staining, caspase activity assays, or TUNEL. In zebrafish embryos, X-ray exposure led to oxidative stress, inflammation, and apoptosis-mediated developmental defects, which were detected using these methods.
Imaging and Radiomics
X-ray and multiparametric MRI radiomics can predict treatment response in osteosarcoma. Longitudinal X-ray-based lung function measurement allows non-invasive monitoring of disease progression and treatment response in mouse models of lung fibrosis. These imaging approaches bridge the gap between molecular responses and clinical outcomes.
How CRISPR Can Be Used to Study GO:0010165 response to X-ray
Knockout
CRISPR knockout of candidate genes such as TP53, ATM, or STING1 allows researchers to test their necessity in the response to X-ray. For example, STING1 knockout melanoma cells can be used to confirm the role of STING in X-ray-induced interferon signaling. Knockout of LPA3 or LPA2 in osteosarcoma cells can reveal their contribution to X-ray sensitivity.
Point Mutation
Introducing specific point mutations via CRISPR base editing or homology-directed repair can model clinically relevant variants. For instance, ATM kinase-dead point mutations can be knocked into cells to study their impact on X-ray-induced checkpoint activation. TP53 hotspot mutations can be modeled to assess radiosensitivity.
Knock-in
Knock-in of reporter tags, such as GFP or luciferase, allows real-time monitoring of X-ray response. A H2AX-GFP knock-in cell line can visualize DNA damage foci after X-ray. Knock-in of NQO1 with a tag can help track its X-ray-induced cascade reactions.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can test gain-of-function effects. Overexpressing NQO1 in cancer cells can enhance X-ray-induced immunogenicity. Overexpression of LPA3 in osteosarcoma cells can modulate X-ray response. These models complement knockout studies to establish causality.
How EDITGENE Supports response to X-ray Research
Researchers studying response to X-ray-related genes often need to determine whether a candidate gene is causally involved in the cellular response, and CRISPR-based models provide a robust way to test this. EDITGENE offers a comprehensive suite of services to generate precisely engineered cell models for such studies.
Contact EDITGENE today to design your custom CRISPR model for response to X-ray research.
Frequently Asked Questions About response to X-ray
What is GO:0010165 response to X-ray?
GO:0010165 is a Gene Ontology biological process term that describes any change in a cell or organism's state or activity as a result of X-ray radiation, including DNA damage, oxidative stress, and transcriptional changes.
What genes are involved in the response to X-ray?
Key genes include TP53, ATM, CHEK2, CDKN1A, STING1, NQO1, and LPA receptors, which regulate DNA repair, cell cycle, and immune signaling.
How does X-ray radiation affect cells?
X-rays cause direct DNA damage and generate reactive oxygen species, leading to activation of DNA damage checkpoints, apoptosis, and immune responses.
What is the role of TP53 in response to X-ray?
TP53 is a master transcription factor that induces cell cycle arrest and apoptosis after X-ray-induced DNA damage, influencing radiosensitivity.
Can CRISPR be used to study response to X-ray?
Yes, CRISPR knockout, knock-in, and overexpression models allow causal testing of genes involved in the X-ray response.
What diseases are associated with defective X-ray response?
Defective X-ray response is linked to cancer radiosensitivity, developmental defects, and fibrosis.
How is the response to X-ray measured experimentally?
Methods include RNA-seq, gamma-H2AX foci staining, comet assay, ROS detection, and apoptosis assays.
What is the difference between proton and X-ray radiation response?
Transcriptome analysis reveals differential gene expression patterns between proton and X-ray radiation, identifying distinct candidate targets.
What is the STING pathway's role in X-ray response?
X-ray irradiation can activate the STING pathway, leading to interferon signaling and enhanced antitumor immunity.
How can EDITGENE help with X-ray response research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression cell models, and library screening services to study genes in the X-ray response pathway.
Conclusion
The response to X-ray (GO:0010165) is a complex biological process with critical implications for cancer therapy, developmental biology, and radiation protection. Advances in transcriptomics, imaging, and CRISPR-based models have illuminated key genes and pathways, from TP53 and ATM to STING and LPA receptors. Continued research using precise genetic tools will further unravel the mechanisms and translate them into clinical benefits.
References
- 1. van den Elzen P et al.. 2023. Alanine response to low energy synchrotron x-ray radiation.. Phys Med Biol 68(6) PMID: 36731142
- 2. Hu W et al.. 2025. X-ray-responsive dissolving microneedles mediate STING pathway activation to potentiate cutaneous melanoma radio-immunotherapy.. Theranostics 15(14):6919-6937 PMID: 40585994
- 3. He L et al.. 2025. X-ray stimulates NQO1-dependent cascade reactions to induce strong immunogenicity for MRI-guided cancer radio-chemodynamic-immunotherapy.. Theranostics 15(14):6768-6788 PMID: 40585976
- 4. Sertorio M et al.. 2021. Differential transcriptome response to proton versus X-ray radiation reveals novel candidate targets for combinatorial PT therapy in lymphoma.. Radiother Oncol 155:293-303 PMID: 33096164
- 5. Khan A et al.. 2023. Longitudinal x-ray based lung function measurement for monitoring Nintedanib treatment response in a mouse model of lung fibrosis.. Sci Rep 13(1):18637 PMID: 37903864
- 6. Ikeda H et al.. 2024. Regulation of cellular responses to X-ray irradiation through the activation of lysophosphatidic acid (LPA) receptor-3 (LPA(3)) and LPA(2) in osteosarcoma cells.. Pathol Res Pract 257:155293 PMID: 38615508
- 7. Karagöz A et al.. 2023. Panoramic dental X-ray exposure leads to oxidative stress, inflammation and apoptosis-mediated developmental defects in zebrafish embryos.. J Stomatol Oral Maxillofac Surg 124(6S):101661 PMID: 37866507
- 8. Luo Z et al.. 2023. Prediction of response to preoperative neoadjuvant chemotherapy in extremity high-grade osteosarcoma using X-ray and multiparametric MRI radiomics.. J Xray Sci Technol 31(3):611-626 PMID: 37005907
